#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study Comparing Mezigdomide, Bortezomib, and Dexamethasone with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Czechia Finland France Germany +7

  • Study of isatuximab, belumosudil and dexamethasone combination treatment for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Greece Italy Norway Portugal

  • Study of isatuximab, evorpacept and dexamethasone combination therapy for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Greece Italy Norway Portugal

  • Study of isatuximab, pomalidomide and dexamethasone combination for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Greece Italy Norway Portugal

  • Cemsidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

    Not yet recruiting

    1 1
    France Italy Poland Spain

  • AZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Norway Poland Spain

  • A study of Cesnicabtagene autoleucel compared to a drug combination for patients with relapsed or refractory multiple myeloma

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands

  • A Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Greece +4

  • A study of the safety and effectiveness of REGN17372 and linvoseltamab in adults with relapsed or refractory multiple myeloma

    Not yet recruiting

    1 1 1
    Investigated drugs:
    Greece

  • Study of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Greece The Netherlands Spain